25 Participants Needed

tDCS + Speech Therapy for Aphasia

SD
SS
Overseen BySidney Schoenrock
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical College of Wisconsin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is tDCS safe for use in humans?

Research shows that transcranial direct current stimulation (tDCS) is generally safe for humans, with no serious adverse events reported in studies involving people with aphasia. It is a noninvasive brain stimulation method that has been safely combined with speech therapy over extended periods.12345

How does the tDCS + Speech Therapy treatment for aphasia differ from other treatments?

The tDCS + Speech Therapy treatment for aphasia is unique because it combines transcranial direct-current stimulation (tDCS), which uses a low-intensity electrical current to modulate brain activity, with traditional speech therapy. This combination aims to enhance the effectiveness of speech therapy by improving brain function and excitability, offering a promising approach for those with aphasia, especially when standard speech therapy alone has limited effectiveness.23567

What data supports the effectiveness of the treatment tDCS + Speech Therapy for Aphasia?

Research shows that transcranial direct-current stimulation (tDCS) combined with speech therapy can improve language abilities in people with aphasia after a stroke. Studies found that active tDCS led to greater language improvements compared to a placebo, and it was safely used over extended periods.23589

Who Is on the Research Team?

SP

Sara Pillay, Ph.D

Principal Investigator

Medical College of Wisconsin

Are You a Good Fit for This Trial?

This trial is for adults who have language difficulties due to brain damage like a stroke. They must speak English fluently and be able to undergo an MRI scan. People with advanced neurodegenerative diseases, severe psychiatric conditions, uncorrectable hearing or vision issues, developmental disabilities, or contraindications to MRI are not eligible.

Inclusion Criteria

You are able to have an MRI scan.
I am an adult who speaks and understands English fluently.
I have language difficulties due to a stroke or brain tumor.

Exclusion Criteria

You have a serious mental illness like schizophrenia, bipolar disorder, or severe depression.
I have an advanced stage of a brain condition like Alzheimer's, epilepsy, Parkinson's, or ALS.
I do not have uncorrectable hearing, vision problems, or learning disabilities.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive targeted or active-control anodal-tDCS with speech therapy for 10 therapy sessions

10 weeks
10 visits (in-person)

Crossover Treatment

Participants crossover to receive the alternative tDCS intervention within the same speech therapy arm

10 weeks
10 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Active Control Transcranial Direct Current Stimulation
  • Targeted Transcranial Direct Current Stimulation
Trial Overview The study tests if mild electrical stimulation (tDCS) combined with speech therapy can help improve language in people who've had a stroke causing aphasia. There are two types of tDCS being tested alongside two kinds of speech therapies focused on different aspects of language.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Targeted tDCS with Semantic-Focused Speech TherapyExperimental Treatment2 Interventions
Group II: Targeted tDCS with Phonologic-Focused Speech TherapyExperimental Treatment2 Interventions
Group III: Active Control tDCS with Phonologic-Focused Speech TherapyActive Control2 Interventions
Group IV: Active Control tDCS with Semantic-Focused Speech TherapyActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Published Research Related to This Trial

Transcranial direct current stimulation (tDCS) combined with speech and language treatment (SLT) is safe for stroke survivors with aphasia, showing no serious adverse events during a six-week treatment involving 30 sessions.
Participants receiving active tDCS exhibited greater improvements in functional language compared to those receiving sham treatment, suggesting that tDCS may enhance the effectiveness of SLT, although the superiority of one stimulation polarity over another remains unclear.
Extended fMRI-Guided Anodal and Cathodal Transcranial Direct Current Stimulation Targeting Perilesional Areas in Post-Stroke Aphasia: A Pilot Randomized Clinical Trial.Cherney, LR., Babbitt, EM., Wang, X., et al.[2021]
In a study of 37 stroke patients, speech therapy combined with transcranial direct current stimulation (tDCS) significantly improved language function, with an average increase in aphasia quotient (AQ%) of 14.94% after treatment.
Patients with less severe, fluent types of aphasia who started treatment within 30 days of their stroke showed the best responses, and those with hemorrhagic strokes had a higher likelihood of improvement compared to those with infarctions.
The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients.Jung, IY., Lim, JY., Kang, EK., et al.[2021]
In a study involving 11 chronic stroke patients with aphasia, dual transcranial direct current stimulation (tDCS) showed a significant improvement in naming response times compared to baseline, suggesting enhanced efficacy over single tDCS.
Both single and dual tDCS improved the number of correct responses in naming tasks, but dual tDCS, which targeted both the left and right inferior frontal gyri, may offer greater benefits for language recovery in stroke patients.
Effects of dual transcranial direct current stimulation for aphasia in chronic stroke patients.Lee, SY., Cheon, HJ., Yoon, KJ., et al.[2021]

Citations

Extended fMRI-Guided Anodal and Cathodal Transcranial Direct Current Stimulation Targeting Perilesional Areas in Post-Stroke Aphasia: A Pilot Randomized Clinical Trial. [2021]
The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients. [2021]
Effects of dual transcranial direct current stimulation for aphasia in chronic stroke patients. [2021]
Transcranial Direct-Current Stimulation in Subacute Aphasia: A Randomized Controlled Trial. [2023]
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial. [2021]
Transcranial direct current stimulation (tDCS) for improving aphasia after stroke: a systematic review with network meta-analysis of randomized controlled trials. [2020]
Clinical Feasibility of Combining Transcranial Direct Current Stimulation with Standard Aphasia Therapy. [2022]
Effect of Anodic Transcranial Direct Current Stimulation Combined With Speech Language Therapy on Nonfluent Poststroke Aphasia. [2022]
Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security